Several pre-clinical studies demonstrated that RANKL/RANK system promotes breast tumorigenesis [23, 24, 26, 27, 46], suggesting that such system may account, at least in part, for the increased incidence of breast cancer associated with use of progesterone and progestins. The gene discussed is TNFRSF11A; the disease is breast carcinoma.